Taysha Gene Therapies, Inc. (TSHA)
4.49
+0.06
(+1.35%)
USD |
NASDAQ |
Oct 09, 16:00
4.49
0.00 (0.00%)
After-Hours: 20:00
Taysha Gene Therapies Total Return Level : 4.49 for Oct. 9, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 09, 2026 | 4.49 |
| October 08, 2026 | 4.43 |
| October 07, 2026 | 4.43 |
| October 06, 2026 | 4.39 |
| October 05, 2026 | 4.49 |
| October 02, 2026 | 4.63 |
| October 01, 2026 | 4.74 |
| September 30, 2026 | 4.87 |
| September 29, 2026 | 4.99 |
| September 28, 2026 | 4.99 |
| September 25, 2026 | 4.67 |
| September 24, 2026 | 4.79 |
| September 23, 2026 | 4.91 |
| September 22, 2026 | 5.16 |
| September 21, 2026 | 5.04 |
| September 18, 2026 | 5.02 |
| September 17, 2026 | 5.16 |
| September 16, 2026 | 5.07 |
| September 15, 2026 | 5.06 |
| September 14, 2026 | 5.01 |
| September 11, 2026 | 5.02 |
| September 10, 2026 | 5.16 |
| September 09, 2026 | 5.34 |
| September 08, 2026 | 5.48 |
| September 04, 2026 | 5.60 |
| Date | Value |
|---|---|
| September 03, 2026 | 5.57 |
| September 02, 2026 | 5.64 |
| September 01, 2026 | 5.70 |
| August 31, 2026 | 5.69 |
| August 28, 2026 | 5.77 |
| August 27, 2026 | 5.96 |
| August 26, 2026 | 6.02 |
| August 25, 2026 | 6.20 |
| August 24, 2026 | 5.97 |
| August 21, 2026 | 6.09 |
| August 20, 2026 | 6.11 |
| August 19, 2026 | 6.43 |
| August 18, 2026 | 6.19 |
| August 17, 2026 | 6.21 |
| August 14, 2026 | 5.95 |
| August 13, 2026 | 5.99 |
| August 12, 2026 | 6.405 |
| August 11, 2026 | 6.68 |
| August 10, 2026 | 6.37 |
| August 07, 2026 | 6.56 |
| August 06, 2026 | 6.34 |
| August 05, 2026 | 6.46 |
| August 04, 2026 | 6.20 |
| August 03, 2026 | 5.78 |
| July 31, 2026 | 5.86 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Altimmune, Inc. | 10.13 |
| Protalix Biotherapeutics, Inc. | 2.78 |
| Humacyte, Inc. | 0.4053 |
| Agenus, Inc. | 7.67 |
| Amgen, Inc. | 621.24 |